Cargando…

Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?

BACKGROUND: The benefits of some second-generation antipsychotics (SGAs) must be weighed against the increased risk for diabetes mellitus. This study examines whether the association between SGAs and diabetes differs by dose. METHODS: Patients were ≥18 years of age from three US healthcare systems a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ulcickas Yood, Marianne, DeLorenze, Gerald N, Quesenberry, Charles P, Oliveria, Susan A, Tsai, Ai-Lin, Kim, Edward, Cziraky, Mark J, McQuade, Robert D, Newcomer, John W, L'Italien, Gilbert J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264670/ https://www.ncbi.nlm.nih.gov/pubmed/22171594 http://dx.doi.org/10.1186/1471-244X-11-197

Ejemplares similares

Cost of Care for HIV-Infected Patients with Co-Occurring Substance Use Disorder or Psychiatric Disease: Report from a Large, Integrated Health Plan
por: DeLorenze, Gerald N., et al.
Publicado: (2014)

Daily intake of antioxidants in relation to survival among adult patients diagnosed with malignant glioma
por: DeLorenze, Gerald N, et al.
Publicado: (2010)

The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913)
por: Hanssens, Linda, et al.
Publicado: (2008)

Incidence and cost of treatment-emergent comorbid events in insured patients with chronic hepatitis C virus infection: a retrospective cohort study
por: Sapra, Sandhya, et al.
Publicado: (2014)

Sustained Hyperglycemia Among Patients With Diabetes: What matters when action is needed?
por: Lafata, Jennifer E., et al.
Publicado: (2009)

Impact of early intervention and disease modification in patients with predementia Alzheimer’s disease: a Markov model simulation
por: Budd, David, et al.
Publicado: (2011)

Measurement properties of the Flu-Like Symptom Index from the Hepatitis Physical Symptom Severity Diary
por: Mathias, Susan, et al.
Publicado: (2013)

Review of patient-reported outcome measures in chronic hepatitis C
por: Kleinman, Leah, et al.
Publicado: (2012)

Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics and Suicide and All-Cause Mortality in Patients With Newly Diagnosed Schizophrenia
por: Huang, Cheng-Yi, et al.
Publicado: (2021)

Potential misinterpretations caused by collapsing upper categories of comorbidity indices: An illustration from a cohort of older breast cancer survivors
por: Ahern, Thomas P, et al.
Publicado: (2009)

Multi-database study of multiple sclerosis: identification, validation and description of MS patients in two countries
por: Persson, Rebecca, et al.
Publicado: (2019)

A Framework for Estimating the Eligible Patient Population for New Migraine Acute Therapies in the United States
por: Harris, Linda, et al.
Publicado: (2021)

Periodontal disease and effects of antipsychotic medications in patients newly diagnosed with schizophrenia: a population-based retrospective cohort
por: Hu, Kai-Fang, et al.
Publicado: (2019)

Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study
por: Haque, Reina, et al.
Publicado: (2017)

Impact of Refractory Myasthenia Gravis on Health-Related Quality of Life
por: Boscoe, Audra N., et al.
Publicado: (2019)

Economic Impact of Early-in-Hospital Diagnosis and Initiation of Eculizumab in Atypical Haemolytic Uraemic Syndrome
por: Ryan, Michael, et al.
Publicado: (2019)

Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer
por: Yardley, Denise A., et al.
Publicado: (2014)

Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant – post hoc results from an open label safety study (BHV3000–201)
por: Johnston, Karissa, et al.
Publicado: (2022)

Rimegepant, Ubrogepant, and Lasmiditan in the Acute Treatment of Migraine Examining the Benefit-Risk Profile Using Number Needed to Treat/Harm
por: Johnston, Karissa M, et al.
Publicado: (2022)

Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer
por: Rugo, Hope S., et al.
Publicado: (2013)

Differences in Prenatal Tobacco Exposure Patterns among 13 Race/Ethnic Groups in California
por: Hoshiko, Sumi, et al.
Publicado: (2019)

Independent Maternal and Fetal Genetic Effects on Midgestational Circulating Levels of Environmental Pollutants
por: Traglia, Michela, et al.
Publicado: (2017)

Real‐world assessment of the relationship between migraine‐related disability and healthcare costs in the United States
por: Harris, Linda, et al.
Publicado: (2022)

The burden of medication overuse headache and patterns of switching and discontinuation among triptan users: a systematic literature review
por: Deighton, Alison M., et al.
Publicado: (2021)

Observational Analysis of the Costs Associated with Acute Treatment of Breakthrough Migraine Attacks in Medicaid Patients Using Preventive Therapies
por: Harris, Linda, et al.
Publicado: (2023)

Advances in the treatment of newly diagnosed glioblastoma
por: Theeler, Brett J., et al.
Publicado: (2015)

Trends and Contributing Factors for Prescribing Antipsychotics in Newly Diagnosed Parkinson’s Disease Patients: A Population-Based Study
por: Orayj, Khalid
Publicado: (2021)

Efficacy and Tolerance of Antipsychotics Used for the Treatment of Patients Newly Diagnosed with Schizophrenia: A Systematic Review and Meta-Analysis
por: Sherzad Qadir, Zina, et al.
Publicado: (2023)

Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study
por: Kaufman, Peter A., et al.
Publicado: (2012)

Matching‐adjusted indirect comparisons of oral rimegepant versus placebo, erenumab, and galcanezumab examining monthly migraine days and health‐related quality of life in the treatment of migraine
por: Popoff, Evan, et al.
Publicado: (2021)

Osteoarthritis of the Knee
por: McQuade, Jean
Publicado: (2015)

Compulsory Health Insurance
por: McQuade, Jerry
Publicado: (1920)

Multicountry Burden of Chronic Hepatitis C Viral Infection among Those Aware of Their Diagnosis: A Patient Survey
por: DiBonaventura, Marco daCosta, et al.
Publicado: (2014)

Cardiovascular Events Associated with Antipsychotics in Newly Diagnosed Parkinson’s Disease Patients: A Propensity Score Matched Cohort Study
por: Orayj, Khalid
Publicado: (2021)

Thyroid Hormones and Moderate Exposure to Perchlorate during Pregnancy in Women in Southern California
por: Steinmaus, Craig, et al.
Publicado: (2015)

Digit ratio links prenatal hormone exposure with adult lung function
por: McQuade, Denise Brooks
Publicado: (2014)

Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant
por: Johnston, Karissa M., et al.
Publicado: (2021)

Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
por: Divac, Nevena, et al.
Publicado: (2014)

Cross-genetic determination of maternal and neonatal immune mediators during pregnancy
por: Traglia, Michela, et al.
Publicado: (2018)

Health State Utility Mapping of Rimegepant for the Preventive Treatment of Migraine: Double-Blind Treatment Phase and Open Label Extension (BHV3000-305)
por: Powell, Lauren C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6p4ltoat3gopinedj68f50u9qt